Risk Factors of the Bladder Cancer
DOI:
https://doi.org/10.12775/QS.2025.39.59295Keywords
bladder cancer, risk factorsAbstract
Introduction and purpose: Bladder cancer [BC] is one of the most common cancers in the world. The number of cases of BC recorded in the National Cancer Registry has been approximately 7.5 thousand annually since 2013. The National Cancer Registry's "Cancer in Poland in 2021" report ranks BC as the 4 most frequent cancer in men in Poland. A deeper comprehension of the disease will aid in the creation of more effective preventative and therapeutic measures. Our effort aims to categorize and characterize risk factors [RF] for BC.
Review Methods: A systematic search of the ‘’PubMed’’ database was conducted, focusing on studies published within the last 5 years. The search strategy used relevant key words related to BC and RF. Studies were included if they provided information on RF associated with BC in the adult population. The articles most pertinent to the subject have been chosen.
State of knowledge: BC is recognized to have several RF. Current studies suggest that smoking is the most important RF. Other factors that increase the risk of BC include, for ex. occupational exposures to arsenic, toluene, rubber, petroleum products, agricultural chemicals, dyes, aromatic amines. BC development is also influenced by a positive family history of BC and diesel exhaust emissions, certain dietary components, low physical activity, obesity, diabetes, male sex, and older age. Decreased risk of BC is observed in cases of higher consumption of MUFAs, plant-based oils, fish, some fruits and vegetables.
Summary: Variety of environmental, genetic and medical factors are considered with an increased risk of BC. Studies of RF for this disease may help in the development of prevention, enabling the implementation of proper screening programs and diagnostic procedures. More research on this subject is necessary to completely comprehend the etiopathology of BC, identify all RF, and determine whether they may be used in the process of treatment.
References
1. Joanna A. Didkowska, Urszula Wojciechowska, Klaudia Barańska, Marta Miklewska, Irmina Michałek, Paweł Olasek ,,Cancer in Poland in 2021” Maria Skłodowska-Curie National Institute of Oncology – National Research Institute; 2023.
2. Dobruch J, Oszczudłowski M. Bladder Cancer: Current Challenges and Future Directions. Medicina (Kaunas). 2021 Jul 24;57(8):749. doi: 10.3390/medicina57080749. PMID: 34440955; PMCID: PMC8402079.
3. Leslie SW, Soon-Sutton TL, Aeddula NR. Bladder Cancer. 2024 Aug 15. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30725608.
4. Masaoka H, Matsuo K, Oze I, Kimura T, Tamakoshi A, Sugawara Y, Tsuji I, Sawada N, Tsugane S, Ito H, Wada K, Nagata C, Kitamura T, Zha L, Sakata R, Ozasa K, Lin Y, Mizoue T, Tanaka K, Abe SK, Inoue M. Cigarette Smoking, Smoking Cessation, and Bladder Cancer Risk: A Pooled Analysis of 10 Cohort Studies in Japan. J Epidemiol. 2023 Nov 5;33(11):582-588. doi: 10.2188/jea.JE20220085. Epub 2023 Mar 31. PMID: 36310059; PMCID: PMC10518381.
5. Hadji M, Rashidian H, Marzban M, Rezaianzadeh A, Ansari-Moghaddam A, Bakhshi M, Nejatizadeh A, Seyyedsalehi MS, Naghibzadeh-Tahami A, Haghdoost A, Mohebbi E, Freedman ND, Malekzadeh R, Etemadi A, Kamangar F, Weiderpass E, Pukkala E, Boffetta P, Zendehdel K. Unveiling an Association between Waterpipe Smoking and Bladder Cancer Risk: A Multicenter Case-Control Study in Iran. Cancer Epidemiol Biomarkers Prev. 2024 Apr 3;33(4):509-515. doi: 10.1158/1055-9965.EPI-23-0773. PMID: 38180357; PMCID: PMC10988205.
6. Jee Y, Jung KJ, Back JH, Lee SM, Lee SH. Trajectory of smoking and early bladder cancer risk among Korean young adult men. Cancer Causes Control. 2020 Oct;31(10):943-949. doi: 10.1007/s10552-020-01335-8. Epub 2020 Aug 18. PMID: 32812183; PMCID: PMC7458885.
7. Abdolahinia Z, Pakmanesh H, Mirzaee M, Bazrafshan A, Shafiei Bafti M, Shahesmaeili A. Opium and Cigarette Smoking are Independently Associated with Bladder Cancer: The Findings of a Matched Case - Control Study. Asian Pac J Cancer Prev. 2021 Oct 1;22(10):3385-3391. doi: 10.31557/APJCP.2021.22.10.3385. PMID: 34711016; PMCID: PMC8858234.
8. Teleka S, Jochems SHJ, Jirström K, Stocks T. The interaction between smoking and bladder cancer genetic variants on urothelial cancer risk by disease aggressiveness. Cancer Med. 2022 Aug;11(15):2896-2905. doi: 10.1002/cam4.4654. Epub 2022 Mar 13. PMID: 35285182; PMCID: PMC9359879.
9. Gaffney CD, Katims A, D'Souza N, Bjurlin MA, Matulewicz RS. Bladder Cancer Carcinogens: Opportunities for Risk Reduction. Eur Urol Focus. 2023 Jul;9(4):575-578. doi: 10.1016/j.euf.2023.03.017. Epub 2023 Apr 5. PMID: 37028984; PMCID: PMC10524287.
10. Luo LS, Luan HH, Zhang P, Jiang JF, Zeng XT, Huang J, Jin YH. The disease burden of bladder cancer and its attributable risk factors in five Eastern Asian countries, 1990-2019: a population-based comparative study. BMC Public Health. 2024 Sep 4;24(1):2404. doi: 10.1186/s12889-024-19909-5. PMID: 39232688; PMCID: PMC11373407.
11. Jubber I, Ong S, Bukavina L, Black PC, Compérat E, Kamat AM, Kiemeney L, Lawrentschuk N, Lerner SP, Meeks JJ, Moch H, Necchi A, Panebianco V, Sridhar SS, Znaor A, Catto JWF, Cumberbatch MG. Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors. Eur Urol. 2023 Aug;84(2):176-190. doi: 10.1016/j.eururo.2023.03.029. Epub 2023 May 16. PMID: 37198015.
12. Richters A, Aben KKH, Kiemeney LALM. The global burden of urinary bladder cancer: an update. World J Urol. 2020 Aug;38(8):1895-1904. doi: 10.1007/s00345-019-02984-4. Epub 2019 Nov 1. PMID: 31676912; PMCID: PMC7363726.
13. Koutros S, Kogevinas M, Friesen MC, Stewart PA, Baris D, Karagas MR, Schwenn M, Johnson A, Monawar Hosain GM, Serra C, Tardon A, Carrato A, Garcia-Closas R, Moore LE, Nickerson ML, Hewitt SM, Lenz P, Schned AR, Lloreta J, Allory Y, Zhang H, Chatterjee N, Garcia-Closas M, Rothman N, Malats N, Silverman DT. Diesel exhaust and bladder cancer risk by pathologic stage and grade subtypes. Environ Int. 2020 Feb;135:105346. doi: 10.1016/j.envint.2019.105346. Epub 2019 Dec 18. PMID: 31864026; PMCID: PMC8237313.
14. Shala NK, Stenehjem JS, Babigumira R, Liu FC, Berge LAM, Silverman DT, Friesen MC, Rothman N, Lan Q, Hosgood HD, Samuelsen SO, Bråtveit M, Kirkeleit J, Andreassen BK, Veierød MB, Grimsrud TK. Exposure to benzene and other hydrocarbons and risk of bladder cancer among male offshore petroleum workers. Br J Cancer. 2023 Sep;129(5):838-851. doi: 10.1038/s41416-023-02357-0. Epub 2023 Jul 18. PMID: 37464024; PMCID: PMC10449774.
15. Xie S, Friesen MC, Baris D, Schwenn M, Rothman N, Johnson A, Karagas MR, Silverman DT, Koutros S. Occupational exposure to organic solvents and risk of bladder cancer. J Expo Sci Environ Epidemiol. 2024 May;34(3):546-553. doi: 10.1038/s41370-024-00651-4. Epub 2024 Feb 16. PMID: 38365975; PMCID: PMC11222140.
16. Wang Z, Kwan ML, Haque R, Pratt R, Lee VS, Roh JM, Ergas IJ, Cannavale KL, Loo RK, Aaronson DS, Quesenberry CP, Ambrosone CB, Kushi LH, Tang L. Environmental and occupational exposures and prognosis in patients with non-muscle-invasive bladder cancer in the Be-Well Study. Am J Epidemiol. 2024 Jun 3;193(6):863-873. doi: 10.1093/aje/kwad236. PMID: 38055616; PMCID: PMC11466861.
17. Latifovic L, Villeneuve PJ, Parent MÉ, Kachuri L; Canadian Cancer Registries Epidemiology Group; Harris SA. Silica and asbestos exposure at work and the risk of bladder cancer in Canadian men: a population-based case-control study. BMC Cancer. 2020 Mar 3;20(1):171. doi: 10.1186/s12885-020-6644-7. PMID: 32126982; PMCID: PMC7055116.
18. Dianatinasab M, Wesselius A, Salehi-Abargouei A, Yu EYW, Fararouei M, Brinkman M, van den Brandt P, White E, Weiderpass E, Le Calvez-Kelm F, Gunter MJ, Huybrechts I, Zeegers MP. Dietary fats and their sources in association with the risk of bladder cancer: A pooled analysis of 11 prospective cohort studies. Int J Cancer. 2022 Jul 1;151(1):44-55. doi: 10.1002/ijc.33970. Epub 2022 Feb 25. Erratum in: Int J Cancer. 2023 Mar 1;152(5):E4-E5. doi: 10.1002/ijc.34370. PMID: 35182086; PMCID: PMC9303525.
19. Dianatinasab M, Forozani E, Akbari A, Azmi N, Bastam D, Fararouei M, Wesselius A, Zeegres MP. Dietary patterns and risk of bladder cancer: a systematic review and meta-analysis. BMC Public Health. 2022 Jan 11;22(1):73. doi: 10.1186/s12889-022-12516-2. PMID: 35016647; PMCID: PMC8753903.
20. Dianatinasab M, Wesselius A, de Loeij T, Salehi-Abargouei A, Yu EYW, Fararouei M, Brinkman M, van den Brandt P, White E, Weiderpass E, Le Calvez-Kelm F, Gunter MJ, Huybrechts I, Liedberg F, Skeie G, Tjonneland A, Riboli E, Zeegers MP. The association between meat and fish consumption and bladder cancer risk: a pooled analysis of 11 cohort studies. Eur J Epidemiol. 2021 Aug;36(8):781-792. doi: 10.1007/s10654-021-00762-4. Epub 2021 May 25. PMID: 34036467; PMCID: PMC8416827.
21. Teng C, Lu W, Che J, Wu Y, Meng D, Shan Y. Association of Pro-Inflammatory Diet, Smoking, and Alcohol Consumption with Bladder Cancer: Evidence from Case-Control and NHANES Studies from 1999 to 2020. Nutrients. 2024 Jun 6;16(11):1793. doi: 10.3390/nu16111793. PMID: 38892724; PMCID: PMC11174752.
22. Boot IWA, Wesselius A, Jochems SHJ, Yu EYW, Bosetti C, Taborelli M, Porru S, Carta A, Golka K, Jiang X, Stern MC, Kellen E, Pohlabeln H, Tang L, Karagas MR, Zhang ZF, Taylor JA, La Vecchia C, Zeegers MP. Fruits and vegetables intake and bladder cancer risk: a pooled analysis from 11 case-control studies in the BLadder cancer Epidemiology and Nutritional Determinants (BLEND) consortium. Eur J Nutr. 2024 Oct;63(7):2477-2498. doi: 10.1007/s00394-024-03436-5. Epub 2024 Jun 5. PMID: 38839633; PMCID: PMC11490439.
23. Wigner P, Bijak M, Saluk-Bijak J. Clinical Potential of Fruit in Bladder Cancer Prevention and Treatment. Nutrients. 2022 Mar 8;14(6):1132. doi: 10.3390/nu14061132. PMID: 35334790; PMCID: PMC8951059.
24. Al-Zalabani AH, Wesselius A, Yi-Wen Yu E, van den Brandt P, Grant EJ, White E, Skeie G, Liedberg F, Weiderpass E, Zeegers MP. Tea consumption and risk of bladder cancer in the Bladder Cancer Epidemiology and Nutritional Determinants (BLEND) Study: Pooled analysis of 12 international cohort studies. Clin Nutr. 2022 May;41(5):1122-1130. doi: 10.1016/j.clnu.2022.03.020. Epub 2022 Mar 29. PMID: 35413574.
25. Qiu Y, Jiang Z, Zhang J. Causal effects of BMI, waist circumference, and body fat percentage on the risk of bladder cancer: A Mendelian randomization study. Medicine (Baltimore). 2024 May 17;103(20):e38231. doi: 10.1097/MD.0000000000038231. PMID: 38758881; PMCID: PMC11098251.
26. Tzelves L, Xenou D, Skolarikos A, Varkarakis I, Deliveliotis C, Terpos E, Stamatelopoulos K, Sergentanis TN, Psaltopoulou T. Association of obesity and other anthropometric characteristics with bladder cancer risk: a systematic review and meta-analysis of longitudinal cohort studies. J BUON. 2021 May-Jun;26(3):1040-1055. PMID: 34268971.
27. Shih HJ, Lin KH, Wen YC, Fan YC, Tsai PS, Huang CJ. Increased risk of bladder cancer in young adult men with hyperlipidemia: A population-based cohort study. Medicine (Baltimore). 2021 Dec 3;100(48):e28125. doi: 10.1097/MD.0000000000028125. PMID: 35049242; PMCID: PMC9191375.
28. Xi Y, Yang Y, Wang Z, Wang J. Higher genetically predicted triglyceride level increases the bladder cancer risk independent of LDL and HDL levels. Sci Rep. 2024 Aug 12;14(1):18652. doi: 10.1038/s41598-024-69737-1. PMID: 39134790; PMCID: PMC11319622.
29. van den Brandt PA. Diabetes and the risk of bladder cancer subtypes in men and women: results from the Netherlands Cohort Study. Eur J Epidemiol. 2024 Apr;39(4):379-391. doi: 10.1007/s10654-024-01100-0. Epub 2024 Mar 16. PMID: 38492115; PMCID: PMC11101497.
30. Bogumil D, Cortessis VK, Wilkens LR, Le Marchand L, Haiman CA, Maskarinec G, Setiawan VW. Interethnic Differences in Bladder Cancer Incidence and the Association between Type 2 Diabetes and Bladder Cancer in the Multiethnic Cohort Study. Cancer Res Commun. 2023 May 2;3(5):755-762. doi: 10.1158/2767-9764.CRC-22-0288. PMID: 37377897; PMCID: PMC10153456.
31. Hektoen HH, Robsahm TE, Andreassen BK, Stenehjem JS, Axcrona K, Mondul A, Gislefoss RE. Lifestyle associated factors and risk of urinary bladder cancer: A prospective cohort study from Norway. Cancer Med. 2020 Jun;9(12):4420-4432. doi: 10.1002/cam4.3060. Epub 2020 Apr 21. PMID: 32319230; PMCID: PMC7300409.
32. An H, Liu K, Shirai K, Kawasaki R, Tamakoshi A, Iso H. Physical Activity and Bladder Cancer Risk: Findings of the Japan Collaborative Cohort Study. Cancer Res Treat. 2024 Apr;56(2):616-623. doi: 10.4143/crt.2023.962. Epub 2023 Oct 6. PMID: 37817564; PMCID: PMC11016649.
33. Koutros S, Kiemeney LA, Pal Choudhury P, Milne RL, Lopez de Maturana E, Ye Y, Joseph V, Florez-Vargas O, Dyrskjøt L, Figueroa J, Dutta D, Giles GG, Hildebrandt MAT, Offit K, Kogevinas M, Weiderpass E, McCullough ML, Freedman ND, Albanes D, Kooperberg C, Cortessis VK, Karagas MR, Johnson A, Schwenn MR, Baris D, Furberg H, Bajorin DF, Cussenot O, Cancel-Tassin G, Benhamou S, Kraft P, Porru S, Carta A, Bishop T, Southey MC, Matullo G, Fletcher T, Kumar R, Taylor JA, Lamy P, Prip F, Kalisz M, Weinstein SJ, Hengstler JG, Selinski S, Harland M, Teo M, Kiltie AE, Tardón A, Serra C, Carrato A, García-Closas R, Lloreta J, Schned A, Lenz P, Riboli E, Brennan P, Tjønneland A, Otto T, Ovsiannikov D, Volkert F, Vermeulen SH, Aben KK, Galesloot TE, Turman C, De Vivo I, Giovannucci E, Hunter DJ, Hohensee C, Hunt R, Patel AV, Huang WY, Thorleifsson G, Gago-Dominguez M, Amiano P, Golka K, Stern MC; UROMOL Consortium; Yan W, Liu J, Li SA, Katta S, Hutchinson A, Hicks B, Wheeler WA, Purdue MP, McGlynn KA, Kitahara CM, Haiman CA, Greene MH, Rafnar T, Chatterjee N, Chanock SJ, Wu X, Real FX, Silverman DT, Garcia-Closas M, Stefansson K, Prokunina-Olsson L, Malats N, Rothman N. Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights. Eur Urol. 2023 Jul;84(1):127-137. doi: 10.1016/j.eururo.2023.04.020. Epub 2023 May 19. PMID: 37210288; PMCID: PMC10330197.
34. Qu W, Zhang F, Cheng Y, Li J, Zhou J. The impact of genetic variants in the CYP2C8 gene on bladder cancer susceptibility. Front Endocrinol (Lausanne). 2022 Sep 28;13:989030. doi: 10.3389/fendo.2022.989030. PMID: 36246885; PMCID: PMC9554954.
35. Gautam KA, Raghav A, Sankhwar SN, Singh R, Tripathi P. Genetic Polymorphisms of Gene Methionine Synthase Reductase (MTRR) and Risk of Urinary Bladder Cancer. Asian Pac J Cancer Prev. 2023 Apr 1;24(4):1137-1141. doi: 10.31557/APJCP.2023.24.4.1137. PMID: 37116134; PMCID: PMC10352732.
36. Song DM, Shen T, Feng K, He YB, Chen SL, Zhang Y, Luo WF, Han L, Tong M, Jin Y. LIG1 is a novel marker for bladder cancer prognosis: evidence based on experimental studies, machine learning and single-cell sequencing. Front Immunol. 2024 Aug 21;15:1419126. doi: 10.3389/fimmu.2024.1419126. PMID: 39234248; PMCID: PMC11371609.
37. Elsalem L, Al Shatnawi A, A Alfaqih M, Alshoh A, Al Demour S, Al-Daghmin A, Halalsheh O, Kheirallah K, Ahram M. Discovery of a novel genetic variant in the N-acetyltransferase2 (NAT2) gene that is associated with bladder cancer risk. Acta Biochim Pol. 2023 Aug 18;70(3):575-582. doi: 10.18388/abp.2020_6590. PMID: 37595067.
38. He Q, Wu S, Zhou Y, Liu Y, Xia B, Li W, Zhao J, Mi N, Xie P, Qin X, Yuan J, Pan Y. Genetic factors, adherence to healthy lifestyle behaviors, and risk of bladder cancer. BMC Cancer. 2023 Oct 12;23(1):965. doi: 10.1186/s12885-023-11455-4. PMID: 37828430; PMCID: PMC10568887.
39. Teleka S, Orho-Melander M, Liedberg F, Melander O, Jirström K, Stocks T. Interaction between blood pressure and genetic risk score for bladder cancer, and risk of urothelial carcinoma in men. Sci Rep. 2022 Oct 31;12(1):18336. doi: 10.1038/s41598-022-23225-6. PMID: 36316463; PMCID: PMC9622916.
40. Avirmed S, Khuanbai Y, Sanjaajamts A, Selenge B, Dagvadorj BU, Ohashi M. Modifying Effect of Smoking on GSTM1 and NAT2 in Relation to the Risk of Bladder Cancer in Mongolian Population: A Case-Control Study. Asian Pac J Cancer Prev. 2021 Aug 1;22(8):2479-2485. doi: 10.31557/APJCP.2021.22.8.2479. PMID: 34452561; PMCID: PMC8629459.
41. Pemov A, Wegman-Ostrosky T, Kim J, Koutros S, Douthitt B, Jones K, Zhu B, Baris D, Schwenn M, Johnson A, Karagas MR, Carter BD, McCullough ML, Landi MT, Freedman ND, Albanes D, Silverman DT, Rothman N, Caporaso NE, Greene MH, Fraumeni JF Jr, Stewart DR. Identification of Genetic Risk Factors for Familial Urinary Bladder Cancer: An Exome Sequencing Study. JCO Precis Oncol. 2021 Dec 22;5:PO.21.00115. doi: 10.1200/PO.21.00115. PMID: 34964002; PMCID: PMC8710334.
42. Yu EY, Stern MC, Jiang X, Tang L, van den Brandt PA, Lu CM, Karagas MR, La Vecchia C, Bosetti C, Polesel J, Golka K, Zhang ZF, Villeneuve P, Zeegers MP, Wesselius A. Family History and Risk of Bladder Cancer: An Analysis Accounting for First- and Second-degree Relatives. Cancer Prev Res (Phila). 2022 May 3;15(5):319-326. doi: 10.1158/1940-6207.CAPR-21-0490. PMID: 35027464.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Joanna Miśkiewicz, Aleksandra Sadowska, Aleksandra Welkier, Adam Sobiński, Aleksandra Dudek, Patrycja Pietrusińska, Jakub Moder, Anna Dziewierz, Paula Kwaśniewska, Patrycja Śliwa-Tytko

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 32
Number of citations: 0